PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

288 hedge funds and large institutions have $4.79B invested in Vaxcyte in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 128 increasing their positions, 74 reducing their positions, and 74 closing their positions.

Holders
288
Holders Change
-22
Holders Change %
-7.1%
% of All Funds
3.87%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.11%
New
57
Increased
128
Reduced
74
Closed
74
Calls
$10.4M
Puts
$4.81M
Net Calls
+$5.55M
Net Calls Change
+$1.23M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$195M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$478M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$100M
4
PBA
4
Paradigm Biocapital Advisors
New York
$110M
5
DTC
5
Deep Track Capital
Connecticut
$69.9M

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$30.5M
2
CC
2
Commodore Capital
New York
$0
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$4.6M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$161M
5
Capital Research Global Investors
5
Capital Research Global Investors
California
$155M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$478M 14,691,344 +2,925,863 +25%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$395M 12,151,050 -361,184 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$390M 11,997,085 -46,720 -0.4%
RCM
4
RA Capital Management
Massachusetts
$389M 11,965,991 -223,158 -2%
BlackRock
5
BlackRock
New York
$346M 10,642,243 +62,766 +0.6%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$195M 6,001,124 +3,298,433 +122%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$161M 4,954,804 -1,462,126 -23%
State Street
8
State Street
Massachusetts
$161M 4,942,235 +534,552 +12%
Capital Research Global Investors
9
Capital Research Global Investors
California
$155M 4,771,786 -1,338,322 -22%
PBA
10
Paradigm Biocapital Advisors
New York
$110M 3,372,837 +1,676,356 +99%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$103M 3,170,247 -371,760 -10%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$100M 3,088,450 +2,220,559 +256%
KCM
13
Kynam Capital Management
New Jersey
$99.9M 3,071,588 -128,412 -4%
Westfield Capital Management
14
Westfield Capital Management
Massachusetts
$99.8M 3,068,898 +913,761 +42%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$97.9M 3,011,140 +142,086 +5%
DTC
16
Deep Track Capital
Connecticut
$69.9M 2,150,000 +1,400,000 +187%
Charles Schwab
17
Charles Schwab
California
$46.1M 1,417,711 +84,329 +6%
Jennison Associates
18
Jennison Associates
New York
$45.5M 1,399,299 +273,579 +24%
UBS Group
19
UBS Group
Switzerland
$44.9M 1,380,853 +300,457 +28%
MC
20
Maverick Capital
Texas
$42.6M 1,310,605 +102,512 +8%
PBPIA
21
Pivotal bioVenture Partners Investment Advisor
California
$42.4M 1,305,125 +594,391 +84%
EP
22
Eversept Partners
New York
$42.2M 1,298,514 +741,444 +133%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$39M 1,198,770 -701,409 -37%
Pictet Asset Management
24
Pictet Asset Management
Switzerland
$38.2M 1,175,661 +124,983 +12%
Northern Trust
25
Northern Trust
Illinois
$36.5M 1,121,892 -1,064 -0.1%
1
2 3 4 5